Other proposed mechanisms of drug resistance include metabolic substances that increase IFN-γ production by T cells [101], bacterial translocation from the gut to the TME [102], cross-reactivity between cancer antigens and microbial peptides [103], and the direct presentation of bacterial peptides by cancer cells [104]. The gene discussed is IFNG; the disease is cancer.